{"DataElement":{"publicId":"2738491","version":"1","preferredName":"Post Hematopoietic Cell Transplantation Therapeutic Procedure Plan Administration Yes No Character Indicator","preferredDefinition":"The indicator that describes whether or not the administration of additional post-hematopoietic cell transplantation therapy was planned.","longName":"PT_HCT_TX_PL_AD_IND","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2738489","version":"2","preferredName":"Post Hematopoietic Cell Transplantation Therapeutic Procedure Plan Administration","preferredDefinition":"Happening at a time subsequent to a reference time; later in time or order._Primitive blood cells derived from embryonic mesenchyme capable of differentiating into any of the blood cell line progenitor cells (erythroblasts, young granulocytic series cells, megakaryocytes, etc.)_The grafting of tissues from one individual to another or place to place within a single individual._An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process._To devise, contrive, or formed in design._The act of the dispensing, applying, or tendering of something to another, such as administration of a medicine.","longName":"PST_HCT_TX_PLN_ADM","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2738477","version":"1","preferredName":"Post Hematopoietic Stem Cell Transplantation Therapeutic Procedure","preferredDefinition":"Post; occuring after.:Primitive blood cells derived from embryonic mesenchyme capable of differentiating into any of the blood cell line progenitor cells (erythroblasts, young granulocytic series cells, megakaryocytes, etc.):The grafting of tissues from one individual to another or place to place within a single individual.:An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","longName":"C38008:C12551:C15342:C49236","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Post","conceptCode":"C38008","definition":"Happening at a time subsequent to a reference time; later in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Hematopoietic Stem Cell","conceptCode":"C12551","definition":"Primitive blood cells derived from embryonic mesenchyme capable of differentiating into any of the blood cell line progenitor cells (erythroblasts, young granulocytic series cells, megakaryocytes, etc.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Transplantation","conceptCode":"C15342","definition":"Transference of a tissue or organ within an individual, between individuals of the same species, or between individuals of different species.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"49C080E0-4508-2327-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-03-31","endDate":null,"createdBy":"ALEYR","dateCreated":"2008-03-31","modifiedBy":"ONEDATA","dateModified":"2008-03-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2671279","version":"1","preferredName":"Planned Administration","preferredDefinition":"Planned; devised, contrived, or formed in design.:The act of administration.","longName":"C25619:C25409","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Plan","conceptCode":"C25619","definition":"To devise, contrive, or form in design.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Administration","conceptCode":"C25409","definition":"The act of the dispensing, applying, or tendering of something to another, such as administration of a medicine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"374709E4-7E6C-535B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-08-09","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-08-09","modifiedBy":"ONEDATA","dateModified":"2007-08-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2BE7B3E-8272-3E3E-E040-BB89AD430627","latestVersionIndicator":"Yes","beginDate":"2013-07-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-07-30","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2181608","version":"1","preferredName":"Yes No Character Indicator","preferredDefinition":"Indicator of Yes or No to a question.","longName":"Y_N_CHAR_IND","context":"CCR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"No","valueDescription":"No ","ValueMeaning":{"publicId":"2567170","version":"1","preferredName":"No","longName":"2567170","preferredDefinition":"The non-affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D36F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-13","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-13","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":"Updated to add NCIt concept relationship. Updated VM Short Name to be the Public ID to be consistent with current convention for VM Short Name - DW 10-03-2022","administrativeNotes":"2022.12.29 Alt VM added per ticket request CADSR0001837. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DD7550B5-55CB-3CC4-E034-0003BA12F5E7","beginDate":"2002-03-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-06-25","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Yes","valueDescription":"Yes","ValueMeaning":{"publicId":"2567168","version":"1","preferredName":"Yes","longName":"2567168","preferredDefinition":"The affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D36D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-13","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-13","modifiedBy":"GDEEN","dateModified":"2024-01-02","changeDescription":"12/29/2006 - Updated with NCI Thesaurus definition.","administrativeNotes":"2022.12.29 Alt VM added per ticket request CADSR0001837. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DD7550B5-55CC-3CC4-E034-0003BA12F5E7","beginDate":"2002-07-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-06-25","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"NA","valueDescription":"Not Applicable","ValueMeaning":{"publicId":"5043360","version":"1","preferredName":"Not Applicable","longName":"5043360","preferredDefinition":"Determination of a value is not relevant in the current context.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Applicable","conceptCode":"C48660","definition":"Determination of a value is not relevant in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2421E11B-65A6-151D-E050-BB89AD4378BB","latestVersionIndicator":"Yes","beginDate":"2015-11-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-09","modifiedBy":"DWARZEL","dateModified":"2018-10-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"78D278EE-7E87-3EC1-E053-F662850AB001","beginDate":"2018-10-22","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2018-10-22","modifiedBy":"ONEDATA","dateModified":"2018-10-22","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2320047","version":"1","preferredName":"Indicator","preferredDefinition":"An event, entity or condition that typically characterizes a prescribed environment or situation. Indicators determine or aid in determining whether or not certain stated circumstances exist or criteria are satisfied. (On-line Medical Dictionary)","longName":"C25180","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Indicator","conceptCode":"C25180","definition":"An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"FC6EF0D8-521A-6865-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-07-25","modifiedBy":"ONEDATA","dateModified":"2005-07-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D4A6A07C-5582-25A1-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-03-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-03-03","modifiedBy":"ZHANGWE","dateModified":"2018-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"3553940","version":"1","longName":"BRIDG","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"4133055","version":"1","longName":"Version 3.2","context":"NHLBI"}]},{"publicId":"6685474","version":"1","longName":"Artificial Neural Network Algorithm for BRIDG Mapping","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6685476","version":"1","longName":"Training Set","context":"NCIP"}]}],"AlternateNames":[{"name":"pre_ted_post_tx_brtzmb_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"pre_ted_post_tx_cll_tx_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"pre_ted_post_tx_imatnb_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"pre_ted_post_tx_it_chm_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"pre_ted_post_tx_lc_rad_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"pre_ted_post_tx_lenald_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"pre_ted_post_tx_oth_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"pre_ted_post_tx_ritxan_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"pre_ted_post_tx_thalid_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"bc_post_tx_planned_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"DefinedProcedure:nameCode","type":"HCT_BRIDG","context":"NHLBI"},{"name":"PreTed_add_post_hct_therapy_plan_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"PreTed_post_hct_plan_it_therapy_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"PreTed_post_hct_plan_ther_tyrosine_kinas_inhib_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"PreTed_post_hct_plan_therapy_bortezomib_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"PreTed_post_hct_plan_therapy_cellular_therapy_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"PreTed_post_hct_plan_therapy_dexamethasone_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"PreTed_post_hct_plan_therapy_lenalidomide_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"PreTed_post_hct_plan_therapy_local_radiother_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"PreTed_post_hct_plan_therapy_oth_therapy_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"PreTed_post_hct_plan_therapy_rituximab_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"PreTed_post_hct_plan_therapy_thalidomide_yn","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"Was post-hematopoietic cell t","type":"Preferred Question Text","description":"Was post-hematopoietic cell transplantation therapy planned?","url":null,"context":"NHLBI"},{"name":"Was post-HSCT therapy planned as of Day 0?","type":"Alternate Question Text","description":"Was post-HSCT therapy planned as of Day 0?","url":null,"context":"NHLBI"},{"name":"BRIDG mapping path for CDE:2738491","type":"BRIDG Mapping Path","description":"\"PerformedProcedure [post-HCT therapy] > DefinedProcedure.nameCode(CD).code OR DefinedProcedure.nameCode(CD).originalText WHERE DeffinedProcedure.nameCode = {administer specified therapy} AND DefinedProcedure [post-HCT therapy] > DefinedCompositeRelationship [1] > DefinedActivity.nameCode = \"\"Perform Overall Hematopoietic Stem Cell Transplantation\"\"  [overall HCT process] > DefinedCompositeRelationship [2] > DefinedSubstanceAdministration.nameCode = \"\"Administer Hematopoietic Stem Cell Product {Transplantation}\"\" AND DefinedCompositeRelationship.sequenceNumber [1] IS GREATER THAN DefinedCompositionRelationship.sequenceNumber [2] AND PerformedProcedure.negationIndicator(BL).value = \"\"false\"\" [Yes] OR \"\"true\"\" [No] \"","url":null,"context":"NHLBI"},{"name":"Bortezomib (Velcade)","type":"Alternate Question Text","description":"Bortezomib (Velcade)","url":null,"context":"NHLBI"},{"name":"Cellular therapy (e.g. DCI, DLI)","type":"Alternate Question Text","description":"Cellular therapy (e.g. DCI, DLI)","url":null,"context":"NHLBI"},{"name":"Dexamethosone","type":"Alternate Question Text","description":"Dexamethosone","url":null,"context":"NHLBI"},{"name":"Intrathecal therapy (chemotherapy)","type":"Alternate Question Text","description":"Intrathecal therapy (chemotherapy)","url":null,"context":"NHLBI"},{"name":"Tyrosine kinase inhibitor (e.g. imatinib mesylate)","type":"Alternate Question Text","description":"Tyrosine kinase inhibitor (e.g. imatinib mesylate)","url":null,"context":"NHLBI"},{"name":"Lenalidomide (Revlimid)","type":"Alternate Question Text","description":"Lenalidomide (Revlimid)","url":null,"context":"NHLBI"},{"name":"Local radiotherapy","type":"Alternate Question Text","description":"Local radiotherapy","url":null,"context":"NHLBI"},{"name":"Rituximab (Rituxan, Mabthera)","type":"Alternate Question Text","description":"Rituximab (Rituxan, Mabthera)","url":null,"context":"NHLBI"},{"name":"Thalidomide (Thalomid)","type":"Alternate Question Text","description":"Thalidomide (Thalomid)","url":null,"context":"NHLBI"},{"name":"Other therapy","type":"Alternate Question Text","description":"Other therapy","url":null,"context":"NHLBI"},{"name":"Is additional post-HCT therapy planned?","type":"Application Standard Question Text","description":"Is additional post-HCT therapy planned?","url":null,"context":"NHLBI"},{"name":"Is additional post-HCT therapy planned?","type":"Alternate Question Text","description":"Is additional post-HCT therapy planned?","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"49C0F1CA-F4FB-3D66-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-03-31","endDate":null,"createdBy":"ALEYR","dateCreated":"2008-03-31","modifiedBy":"ALEYR","dateModified":"2019-04-07","changeDescription":". Added human readable def. System generated def displayed as alt def. No version needed. AK10/16/14","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}